Syndax Pharmaceuticals Inc (SNDX) › Total LiabilitiesSyndax Pharmaceuticals Inc (SNDX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $23.20M2016: $24.87M2017: $32.87M2018: $30.89M2019: $31.93M2020: $48.42M2021: $41.29M2022: $29.79M2023: $58.68M2024: $436.69M2025: $465.08M$465.08M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$465.08M+6.5%2024$436.69M+644.1%2023$58.68M+97.0%2022$29.79M-27.9%2021$41.29M-14.7%2020$48.42M+51.7%2019$31.93M+3.3%2018$30.89M-6.0%2017$32.87M+32.1%2016$24.87M+7.2%2015$23.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share